Back to Search Start Over

Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants

Authors :
Ana S. Gonzalez-Reiche
Hala Alshammary
Sarah Schaefer
Gopi Patel
Jose Polanco
Juan Manuel Carreño
Angela A. Amoako
Aria Rooker
Christian Cognigni
Daniel Floda
Adriana van de Guchte
Zain Khalil
Keith Farrugia
Nima Assad
Jian Zhang
Bremy Alburquerque
PARIS/PSP study group
Levy A. Sominsky
Charles Gleason
Komal Srivastava
Robert Sebra
Juan David Ramirez
Radhika Banu
Paras Shrestha
Florian Krammer
Alberto Paniz-Mondolfi
Emilia Mia Sordillo
Viviana Simon
Harm van Bakel
Source :
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Publication Year :
2023
Publisher :
Nature Portfolio, 2023.

Abstract

Abstract Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have been reported in immune-compromised individuals and people undergoing immune-modulatory treatments. Although intrahost evolution has been documented, direct evidence of subsequent transmission and continued stepwise adaptation is lacking. Here we describe sequential persistent SARS-CoV-2 infections in three individuals that led to the emergence, forward transmission, and continued evolution of a new Omicron sublineage, BA.1.23, over an eight-month period. The initially transmitted BA.1.23 variant encoded seven additional amino acid substitutions within the spike protein (E96D, R346T, L455W, K458M, A484V, H681R, A688V), and displayed substantial resistance to neutralization by sera from boosted and/or Omicron BA.1-infected study participants. Subsequent continued BA.1.23 replication resulted in additional substitutions in the spike protein (S254F, N448S, F456L, M458K, F981L, S982L) as well as in five other virus proteins. Our findings demonstrate not only that the Omicron BA.1 lineage can diverge further from its already exceptionally mutated genome but also that patients with persistent infections can transmit these viral variants. Thus, there is, an urgent need to implement strategies to prevent prolonged SARS-CoV-2 replication and to limit the spread of newly emerging, neutralization-resistant variants in vulnerable patients.

Subjects

Subjects :
Science

Details

Language :
English
ISSN :
20411723
Volume :
14
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Nature Communications
Publication Type :
Academic Journal
Accession number :
edsdoj.f68dd420466d4ce3b1c6402bfe4823dc
Document Type :
article
Full Text :
https://doi.org/10.1038/s41467-023-38867-x